Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis

Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis

Abstract Background The effectiveness and safety of neoadjuvant PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors is controversial. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors as neoadjuvant therapy f...

Full description

Bibliographic Details
Main Authors: Shuang Huang, Gang Zheng, Kai Yang
Format: Article
Language:English
Published: BMC 2023-11-01
Series:World Journal of Surgical Oncology
Subjects:
Neoadjuvant therapy
Immune checkpoint inhibitors
PD-1
PD-L1
CTLA-4
Meta-analysis
Online Access:https://doi.org/10.1186/s12957-023-03212-5

Internet

https://doi.org/10.1186/s12957-023-03212-5

Similar Items